Azathioprine-Induced Alopecia And Leukopenia Associated With NUDT15 Polymorphisms

    Ayano Fukushima‐Nomura, Yasushi Kurihara, Masataka Saito, Ayako Fukushima, Yukako Shintani, Rie Shiiyama, Satoshi Toshima, Aki Kamata, Jun Yamagami, Takeru Funakoshi, Kaori Kameyama, Masayuki Amagai, Akiharu Kubo, Noriko Umegaki‐Arao
    TLDR Certain genetic variations can make people more likely to experience hair loss and low white blood cell count from azathioprine.
    The document discussed azathioprine-induced alopecia and leukopenia, which were associated with NUDT15 polymorphisms. The study highlighted that individuals with certain NUDT15 genetic variations were more susceptible to these adverse effects when treated with azathioprine. This finding underscored the importance of genetic screening before administering azathioprine to predict and prevent these side effects. The research was conducted by a team from the Department of Dermatology at Keio University School of Medicine in Tokyo, Japan.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    1 / 1 results

      community Not everyone should immediately go on Fin if they are starting to bald

      in Finasteride/Dutasteride  21 upvotes 2 years ago
      The conversation suggests that people should consult a dermatologist to understand their type of hair loss before starting treatments like finasteride or dutasteride, especially if they have autoimmune issues or low DHT. Some participants believe in starting treatment like finasteride immediately if hair loss is due to DHT, while others recommend ruling out other causes and considering minoxidil first, especially for younger individuals.

    Similar Research

    5 / 734 results